Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 391 to 405 of 1284 results for social care

  1. What opportunities are there to use electronic systems to reduce the health risks associated with cold homes? For example, could temperature alert systems be linked from a smart meter to a health or social care provider?

    temperature alert systems be linked from a smart meter to a health or social care provider? Any explanatory notes(if applicable) None....

    Research recommendation
    Published
    9 June 2015

  2. What lay members do

    member of one of our committees who has personal experience of using health or care services. The phrase could also refer to someone...

  3. What lay members do

    member of one of our committees who has personal experience of using health or care services. The phrase could also refer to someone...

  4. Consultancy service

    Get expert advice and support from NICE International, part of the UK's National Institute for Health and Care Excellence, for a project in your country

  5. Idiopathic pulmonary fibrosis in adults (QS79)

    This quality standard covers managing idiopathic pulmonary fibrosis (gradual scarring of the lungs) in adults. It includes diagnosis by a multidisciplinary team, managing symptoms and palliative care. It describes high-quality care in priority areas for improvement.

    Quality standard
    Published
    29 January 2015
    View quality statements

    Sections for QS79

  6. Corporate publications

    NICE's business plan, annual report, charter, transformation story, gender pay gap report, framework agreement and other publications.

  7. Consultations

    People can comment on our guidance at specific stages in its development.

  8. Consultations

    People can comment on our guidance at specific stages in its development.

  9. Appeal panel membership

    The appeal panel is drawn from a group of people approved by the Secretary of State for Health and Social Care to hear appeals.

  10. Tezepelumab for treating severe chronic rhinosinusitis with nasal polyps [ID6379]

    In development Reference number: GID-TA11429 Expected publication date:  09 September 2026

    Technology appraisal guidance
    In development

  11. Effective interventions for addressing child abuse and neglect in the UK:- What interventions, approaches and methodologies provided by social care and voluntary sectorservices are effective and cost effective in the UK to prevent the recurrence of child abuse and neglect, and to improve the wellbeing of children, young people and families?

    the UK:- What interventions, approaches and methodologies provided by social care and voluntary sectorservices are effective and cost...

    Research recommendation
    Published
    18 October 2018

  12. Pembrolizumab with chemoradiation for untreated high-risk locally advanced cervical cancer [ID6138]

    Awaiting development Reference number: GID-TA11215 Expected publication date:  14 July 2026

    Technology appraisal guidance
    Awaiting development

  13. Sirolimus gel for treating facial angiofibroma from tuberous sclerosis complex in people 6 years and older (review of TA972) [ID6440]

    In development Reference number: GID-TA11554 Expected publication date: TBC

    Technology appraisal guidance
    In development

  14. Tislelizumab for treating unresectable advanced oesophageal squamous cell cancer after platinum-based chemotherapy (review of TA1068) [ID6682]

    Awaiting development Reference number: GID-TA11978 Expected publication date: TBC

    Technology appraisal guidance
    Awaiting development

  15. Trastuzumab deruxtecan for treating HER2-positive advanced gastric or gastro-oesophageal junction adenocarcinoma after trastuzumab-based treatment (review of TA879) [ID6680]

    In development Reference number: GID-TA11963 Expected publication date:  13 January 2027

    Technology appraisal guidance
    In development